LOS ANGELES – September 18, 2019 – ManifestSeven (“M7” and formerly known as MJIC), California’s first integrated omnichannel platform for legal cannabis, is alarmed by reports of respiratory disease allegedly caused by vaping.
The Centers for Disease Control has reported that many recent cases of respiratory illness are either linked to products purchased in states where cannabis is not legal, or involve counterfeit products purchased through unlicensed retailers.
M7 wants to assure our customers that the products we and our regulated cannabis brands – Highlanders, MyJane and Weden – sell both meet and exceed the strict safety standards established by the California Department of Public Health.
As such, we are announcing our support for the California Bureau of Cannabis Control’s #getweedwise campaign to encourage consumers to purchase cannabis only from licensed and regulated businesses.
All legal cannabis products purchased from compliant companies, like M7, must meet strict health and safety requirements under California’s Medicinal and Adult-Use Cannabis Regulation and Safety Act. Compliant products are tested for toxins, residuals, fungi, solvents, heavy metals and pesticides; regulation also ensures consistent dosage and potency.
ManifestSeven is firmly committed to upholding the highest standards, to help ensure that the legal cannabis market remains focused on the health and safety of its consumers.
ManifestSeven (M7), formerly known as MJIC, is the first integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway. ManifestSeven, based in Commerce, California, services the needs of lawful operators across the supply chain, from the cultivator to the consumer, through an expansive network of seven facilities stretching from the San Francisco Bay Area to San Diego. M7 further augments its business-to-business value proposition with a growing portfolio of owned and operated retail operations located in major metro markets, including brick-and-mortar dispensaries, local on-demand delivery services, e-commerce and subscription offerings.
As further described in its April 10, 2019 press release, M7 has entered into a merger agreement with, among others, P&P Ventures Inc. (“P&P”), pursuant to which ManifestSeven will complete a reverse-takeover of P&P (the “Proposed Transaction”). Pursuant to the Proposed Transaction, the shares of ManifestSeven Holdings Corp., the resulting issuer of the Proposed Transaction, are expected to be listed on the Canadian Securities Exchange. Closing of the Proposed Transaction is subject to a number of conditions precedent, including regulatory approval. To learn more, please visit: manifest7.com.
Dave Quast, for ManifestSeven
Joel Labi, ManifestSeven